Matching trials
1,853 results
- PRONTO-PumpIndependent statistical analysis of A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes: primary endpoint results, effect estimate with…
- PRONTO-T1DA detailed statistical analysis of the randomized phase 3 PRONTO-T1D trial of LY900014 in participants with type 1 diabetes, including HbA1c, postprandial glucose, non-inferiority, ANCOVA, mixed-effects modeling, and safety.
- PRONTO-T2DIndependent statistical analysis of A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PROPELIndependent statistical analysis of BAX 855 PK-guided Dosing: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02585960).
- Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size…
- Prophylactic Ivermectin in COVID-19 Contacts: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Ivermectin in COVID-19 Contacts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04422561).
- Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study: Complete Statistical AnalysisIndependent statistical analysis of Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PROSELICAA detailed statistical analysis of the phase 3 PROSELICA trial comparing cabazitaxel 20 mg/m² with 25 mg/m² plus prednisone in metastatic castration resistant prostate cancer, including non-inferiority methodology, overall survival, progression endpoints,…
- ProspectIndependent statistical analysis of A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer: primary endpoint results, effect estimate with…
- PROSPERIndependent statistical analysis of PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01274637).
- PROTECTIndependent statistical analysis of the randomized phase 3 PROTECT trial of sipuleucel-T in prostate cancer, including its time-to-biochemical-failure endpoints, stratified log-rank analysis, hazard ratio, confidence interval, and statistical interpretation.
- Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study: Complete Statistical AnalysisIndependent statistical analysis of Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00604383).
- PROVENTIndependent statistical analysis of Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- PRP vs Corticosteroid in Baker’s Cyst: Complete Statistical AnalysisIndependent statistical analysis of PRP vs Corticosteroid in Baker's Cyst: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02249377).
- PSMA PreRPIndependent statistical analysis of Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02919111).
- Psoriatic Arthritis Study of Izokibep: Complete Statistical AnalysisIndependent statistical analysis of Psoriatic Arthritis Study of Izokibep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05623345).
- PSUNRISE – Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: Complete Statistical AnalysisIndependent statistical analysis of PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Pupillary Unrest as an Indicator of Central Opioid Effect in Subjects 40-60 Years of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- PURPOSE 2Independent statistical analysis of PURPOSE 2, a randomized phase 3 trial of lenacapavir for HIV pre-exposure prophylaxis, including its rate-based primary analyses, Poisson regression, Wald testing, confidence intervals, and statistical interpretation.
- PURSUEComplete statistical analysis of the PURSUE phase 3 trial of a single injection of SCH 900962 versus daily recFSH injections in women undergoing controlled ovarian stimulation for infertility, including non-inferiority methodology, efficacy…
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria: Complete Statistical AnalysisIndependent statistical analysis of Pyronaridine Artesunate (3:1) in Children and Adults With Acute Plasmodium Vivax Malaria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03408483).
- RA-MOBILITYComplete statistical analysis of RA-MOBILITY, evaluating sarilumab on top of methotrexate in rheumatoid arthritis, including ACR20 response, HAQ-DI, structural damage, multiplicity, and registry-reported statistical results.
- Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD): Complete Statistical AnalysisIndependent statistical analysis of Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD): primary endpoint results, effect estimate with…
- RADIANTA detailed statistical analysis and educational interpretation of the RADIANT phase 3 trial of erlotinib versus placebo after surgery in EGFR-positive non-small cell lung cancer, focusing on disease-free survival and time-to-event methodology.
- Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy (RT) and Temozolomide (TMZ) in Treating Patients With Newly Diagnosed Glioblastoma or Gliosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RAINBOIndependent statistical analysis of the RAINBO phase 2/3 trial of molecularly guided adjuvant treatment strategies in endometrial cancer, including trial design, recurrence-free survival endpoints, planned statistical analysis, and interpretation.
- RALLYIndependent statistical analysis of A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized, Double-Blind, Placebo Controlled Study of Vilazodone’s Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD): Complete Statistical AnalysisIndependent statistical analysis of Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Open Label Safety Trial of Dapivirine Vaginal Ring and Oral TRUVADA® Use in Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants: Complete Statistical AnalysisIndependent statistical analysis of Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation: Complete Statistical AnalysisIndependent statistical analysis of Rate Control Versus Rhythm Control For Postoperative Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02132767).
- RE-COVER IComplete statistical analysis of RE-COVER I, the randomized phase 3 trial comparing dabigatran 150 mg with warfarin for 6 months in patients with acute symptomatic venous thromboembolism, including non-inferiority methodology, time-to-event analyses,…
- Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: Complete Statistical AnalysisIndependent statistical analysis of Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00675103).
- RE-MEDYA detailed statistical analysis of the randomized phase 3 RE-MEDY trial comparing dabigatran with warfarin for secondary prevention of venous thromboembolism, including time-to-event methodology, non-inferiority analysis, bleeding outcomes, and statistical interpretation.
- REACTComplete statistical analysis of the REACT phase 3 trial of two years of adjuvant celecoxib versus placebo in primary breast cancer, including trial design, disease-free survival, overall survival, statistical methodology, and interpretation.
- READYComplete statistical analysis of the READY phase 3 trial of docetaxel plus dasatinib versus docetaxel plus placebo in castration-resistant prostate cancer, including trial design, overall survival, secondary endpoints, statistical methodology, safety, and…
- READY-4Independent statistical analysis of Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- REALITYIndependent statistical analysis of the REALITY phase 3 trial (NCT01825031), including trial design, endpoints, planned analysis, factorial design, statistical methodology, and interpretation.
- RECESSComplete statistical analysis of the RECESS phase 3 trial comparing shorter- and longer-storage red blood cell units in patients undergoing cardiac surgery, including MODS, mortality, complications, and statistical methodology.
- RECORDComplete statistical analysis of the RECORD phase 3 trial of rosiglitazone and cardiovascular outcomes in type 2 diabetes, including trial design, time-to-event endpoints, hazard ratios, confidence intervals, non-inferiority analysis, re-adjudication outcomes, safety,…
- RECOVERIndependent statistical analysis of Randomized Evaluation of the 24-Hour Coverage: Efficacy of Rotigotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00474058).
- RECOVERYIndependent statistical analysis of the RECOVERY phase 3 trial, including its factorial design, primary mortality and time-to-discharge endpoints, planned statistical methods, and interpretation of the trial design.
- RED-HFIndependent statistical analysis of the RED-HF phase 3 trial of darbepoetin alfa in heart failure, including trial design, time-to-event endpoints, hazard ratios, KCCQ analyses, safety, methodology, and statistical interpretation.
- REDEFINEIndependent statistical analysis of Reducing Diagnostic Error to Improve Patient Safety in COPD and Asthma (REDEFINE Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…